| abstract |
[PROBLEMS] To provide a pharmaceutical composition effective for treating, preventing, or suppressing fibrous adhesions, peritonitis, ischemia, reperfusion injury, endotoxemia, keloid trauma, keloid, dermatitis, rosacea. A therapeutically effective amount of a modified fucan is included together with at least one pharmaceutically acceptable additive, excipient, base or diluent, the modified fucan being 35-60% w / w. The total carbohydrate content is 37-75% w / w, has a fucose content of 90-100% w / w as a percentage of the total carbohydrate content, acetyl: fucose A pharmaceutical composition for at least one of the treatment or inhibition of fibrotic adhesions having an acetyl content of 0-2% as a ratio and a protein content of 0-2% w / w. [Selection figure] None |